General Comments / Chat, page-10153

That maybe the case for a company that is trading and has little volatility in the SP.
I understand your argument, which is to protect the board for future litigation.

However, RAC is not a trading company so I cannot see how a merchant bank could value RAC.
We have the Triangle Report and as the milestones are achieved the risk moves from 98% to something less.
I still think the board are obligated to advise the full potential of the asset.

As a major Shareholder, Dr. T would also weigh into the argument.
Especially if his involvement as an employee was planned to be terminated.

It really is just academic, because I don't believe a hostile takeover will eventuate.

If something were to happen, don't forget it has been discussed the original board were looking to flip Bisantrene for AML only for circa $30ps. There is your starting point, and every SH would have made a good return.

Cheers